Given that TMPRSS2-ERG increases both the migration in vitro and the subcutaneous tumor development, we then tested whether TMPRSS2-ERG could be taking part in the bone metastasis formation of prostate cancer cells in vivo. This evidence concerns the gene TMPRSS2 and neoplasm.